Longtime Emanate Health Chief Executive Robert Curry will retire in April, the West Covina-based hospital system announced Nov. 30.
Within the space of 24 hours last week, two local pharmaceutical companies inked licensing deals for drugs in development that could reap them up to a combined $1.5 billion if the drugs prove successful.
The Beverly Hills company plans to use the funding to further develop and market its platform to analyze and improve Medicare patient care outcomes.
Business accelerators have long been a crucial link for taking startups from the research and prototype stage to marketing and selling their products and services to customers.
The Oncology Institute raised approximately $334 million in cash proceeds through the public trading launch.
Santa Monica-based PatientPop Inc. will merge with health care IT firm Kareo Inc., forming a new company called Tebra.
Brentwood-based perinatal nutrition company Needed recently closed a $3.7 million round of seed financing to help it continue its research and begin marketing nutritional supplements to women of childbearing age.
Merger Makes Venice Family Clinic the Largest Nonprofit Community Health Center in Coastal LA County
Two of the oldest and largest nonprofit health centers serving coastal Los Angeles County have merged.
A new leadership team is assembling at USC’s health system, with a chief executive and top execs at each of the system’s main hospital components named in the last two months.
Temple City-based Fulgent Genetics Inc. has launched a home Covid test designed to detect specific antibodies that indicate the level of Covid immunity in individuals.
Long Beach-based health insurance giant Molina Healthcare Inc. is deepening its reach into New York, the nation’s largest metro health market.
Culver City-based Science 37 Inc., which completed its merger to go public through New York City-based blank check firm LifeSci Acquisition II Corp. earlier this month, recently began trading. Now, the medical research and technology company is already laying out ambitious plans for growth.
L.A. Care Health Plan, the behemoth Westlake-based provider of health insurance that now covers nearly one in four L.A. County residents, has been broadening its reach, moving into a new market and tackling societal concerns.
Monrovia-based biopharma company Xencor Inc. on Oct. 4 announced its second collaboration and license agreement with Janssen Biotech Inc. in 10 months — this one to develop and commercialize its drug candidate that stimulates T cells to treat certain types of lymphomas.
The demand for Covid-19 testing isn’t slowing down, and Temple City-based Fulgent Genetics Inc. continues to answer the call.